Thus, we here systematically analyzed RNA sequencing (RNA-seq) data obtained from The Cancer Genome Atlas (TCGA) database and identified oncogenic signaling pathways activated in ETV4-fusion-positive prostate cancer, which results in ETV4 overexpression. This evidence concerns the gene ETV4 and prostate cancer.